Achieve Life Sciences, Inc.
US ˙ NasdaqCM ˙ US0044685008

SecurityACHV / Achieve Life Sciences, Inc.
InstitutionFranklin Resources Inc
Latest Disclosed Ownership6,369,252 shares
Ownership 6.20%
Franklin Resources Inc ownership in ACHV / Achieve Life Sciences, Inc.

2026-05-07 - Franklin Resources Inc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,369,252 shares of Achieve Life Sciences, Inc. (US:ACHV). This represents 6.2 percent ownership of the company. In their previous filing dated 2026-01-29 , Franklin Resources Inc had reported owning 6,369,193 shares, indicating an increase of 0.00 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2026-05-07 2026-05-07 13G/A 6,369,193 6,369,252 0.00 6.20 -46.09
2026-01-29 2026-01-29 13G/A 8,640,039 6,369,193 -26.28 11.50 -28.12
2025-08-05 2025-08-05 13G/A 4,639,960 8,640,039 86.21 16.00 26.98
2025-05-09 2025-05-09 13G/A 6,052,374 4,639,960 -23.34 12.60 -24.10
2024-10-31 2024-10-31 13G/A 4,365,755 6,052,374 38.63 16.60 38.33
2024-03-11 2024-03-11 13G 4,365,755 12.00

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ACHIEVE LIFE SCIENCE COM 004468500 4,369,193 0 0.00 12,845 -40.84 0.0005
2026-02-11 2025-12-31 13F ACHIEVE LIFE SCIENCES COM 004468500 4,369,193 4,346,011 18,747.35 21,715 57,042.11 0.0053
2025-11-13 2025-09-30 13F ACCURAY COM 004468500 23,182 -4,435,832 -99.48 39 -99.62 0.0000
2025-08-12 2025-06-30 13F ACHIEVE LIFE SCIENCES COM 004468500 4,459,014 2,000,079 81.34 10,077 53.50 0.0027
2025-05-13 2025-03-31 13F ACHIEVE LIFE SCIENCES COM 004468500 2,458,935 -1,393,301 -36.17 6,565 -51.58 0.0019
2025-02-12 2024-12-31 13F ACHIEVE LIFE SCIENCES COM 004468500 3,852,236 -19,113 -0.49 13,560 -29.81 0.0038
2024-11-27 2024-09-30 13F/A-1 ACHIEVE LIFE SCIENCES COM 004468500 3,871,349 -2,181,025 -36.04 19,318 -1.43 0.0054
2024-11-12 2024-09-30 13F ACHIEVE LIFE SCIENCES COM 004468500 3,871,349 -2,181,025 19,318 0.0009
2024-08-14 2024-06-30 13F ACHIEVE LIFE SCIENCES COM 004468500 6,052,374 88,286 1.48 19,599 13.98 0.0060
2024-05-13 2024-03-31 13F ACHIEVE LIFE SCIENCES COM 004468500 5,964,088 5,964,088 17,194 0.0054
2022-11-14 2022-09-30 13F ACHIEVE LIFE SCIENCES COM 004468500 0 -23,536 -100.00 0 -100.00
2022-08-11 2022-06-30 13F ACHIEVE LIFE SCIENCES COM 004468500 23,536 -10,431 -30.71 115 -55.25 0.0001
2022-05-13 2022-03-31 13F ACHIEVE LIFE SCIENCES COM 004468500 33,967 0 0.00 257 -2.65 0.0001
2022-02-11 2021-12-31 13F ACHIEVE LIFE SCIENCES COM 004468500 33,967 -83 -0.24 264 -8.65 0.0001
2021-11-12 2021-09-30 13F ACHIEVE LIFE SCIENCES COM 004468500 34,050 34,050 289 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.